Clinical trials
Venous Thromboembolism (VTE) clinical trials
Below are recruiting venous thromboembolism (vte) clinical trials, each written for real people, not researchers. We’re tracking 53 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07493304RecruitingPhase 3
Preventing blood clots in people with cancer
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
Hialeah, FloridaAges 18 years+ - NCT04211181Recruiting
Prevent blood clots in hospitalized teens and adults
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
Beijing, Beijing MunicipalityAges 14 years+ - NCT05378308Recruiting
Tracking blood thinner use in people with AF or blood clots
This registry study looks at how people with atrial fibrillation (AF) or blood clots (VTE) use blood thinners, especially NOACs, over time. It may help doctors better understand real-world patterns of treatment and outcomes.
Zhengzhou, HenanAges Any age - NCT06393868RecruitingPhase 3
Preventing stomach bleeding with omeprazole during blood thinner therapy
This trial tests whether omeprazole (a stomach acid reducer) can help prevent stomach bleeding in older adults who are taking blood thinners for a newly diagnosed blood clot. It may be a good fit if you are 65 or older and starting blood thinners for a clot.
Ottawa, OntarioAges 65 years+ - NCT06831474RecruitingPhase 1
Rivaroxaban in breast milk after childbirth
This study looks at how a blood thinner called rivaroxaban enters breast milk after delivery. It may help women who need this medication while breastfeeding.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06845423RecruitingPhase 4
Preventing blood clots after childbirth in women at intermediate risk
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
AmiensAges 18 years+ - NCT06958588RecruitingPhase 4
PEMF therapy vs. leg compression for blood clot prevention in ICU
This trial is testing two different ways to prevent dangerous blood clots in ICU patients who cannot take blood-thinning medication. It compares a pulsed electromagnetic field device (PEMF) to a standard leg compression device. Both treatments are non-invasive and used without medication.
Belo Horizonte, BHAges Any age - NCT07270263Recruiting
Lower-dose blood thinners for people with blood cancers
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT07310693Recruiting
Validating a score to find hidden cancer in blood clot patients
This study tests how well a scoring system (CLOVER) can detect undiagnosed cancer in people who have had a blood clot (deep vein thrombosis or pulmonary embolism). Researchers want to see if the score can predict hidden cancer, which may lead to earlier treatment.
Barcelona, BarcelonaAges 18 years+ - NCT02156401Recruiting
Study of tests and care to improve clot diagnosis
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Mainz, Rhineland-PalatinateAges 18 years+ - NCT07399977Recruiting
Blood test to guide blood thinner use in cancer
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Basking Ridge, New JerseyAges 18 years+ - NCT06350331Enrolling by invitation
Smarter blood clot care with phone/tablet help
This study tests if using a smartphone app or tablet helps doctors and patients work together to prevent or manage blood clots in the legs or lungs. It is for adults in the hospital who have or are at high risk of a blood clot.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03659708Recruiting
Study to prevent dangerous blood clots during pregnancy
This study looks at pregnancy-related risk for a dangerous blood clot in the leg or lung (venous thromboembolism). It focuses on pregnant people who already have a higher-than-average risk and wants to see how to manage that risk safely.
BronAges 18–50 - NCT03781531Recruiting
Blood tests to find hidden cancer after a blood clot
This study looks for “biomarkers,” or blood signs, that may help detect hidden (occult) cancer in people who recently had a blood clot in the leg or a lung clot. It may help doctors catch cancer earlier by improving detection after venous thromboembolism.
StockholmAges 18 years+ - NCT02832245Recruiting
Registry for people with blood clots in veins or lungs
This is a “registry” study that collects information about people who have a confirmed blood clot in a vein, lung, or a superficial vein. It may help doctors understand outcomes over time, especially what happens in the first few months after diagnosis.
New Haven, ConnecticutAges Any age - NCT06057844Recruiting
PET scan to detect active blood clots
This study uses a special PET scan to see if it can detect active blood clots. It is looking for healthy volunteers to help test the imaging method, not people who already have a clot.
BrestAges 18 years+ - NCT06611319RecruitingPhase 3
Shorter blood thinner after hip replacement: a recovery study
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
Linz, Upper AustriaAges 18–85 - NCT06731244Recruiting
Deciding about blood thinners after a first clot
This study helps you and your doctor decide together whether to continue blood thinners after a first unexpected blood clot. You join after 3 to 6 months of treatment to discuss your options.
Brest, FranceAges 18 years+ - NCT05627375RecruitingPhase 3
Blood thinner options for clot patients already on antiplatelets
This Phase 3 trial compares the best “blood thinner” approach for people who have a new clot in the leg (DVT) or lung (PE) and who already take antiplatelet medicines for heart or blood-vessel prevention. It aims to find an antithrombotic plan that lowers clot risk while managing bleeding risk.
AmiensAges 18 years+ - NCT07213778RecruitingPhase 3
Comparing a new drug to aspirin for blood clot prevention after knee replacement
This trial tests a new medicine called REGN7508 against aspirin to prevent blood clots after total knee replacement surgery. It may help if you are having a planned knee replacement and are in good health.
La Mesa, CaliforniaAges 18 years+ - NCT07288632Recruiting
Lung cancer gene test and blood clot risk study
This study looks at whether certain gene profiles in advanced lung cancer affect the risk of blood clots. It may help doctors better understand and prevent clots in people starting new cancer treatment.
Perugia, PerugiaAges 18 years+ - NCT07140211RecruitingPhase 3
Low-dose heparin to prevent blood clots after childbirth
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
BadenAges 18 years+ - NCT07015905RecruitingPhase 3
Study of REGN7508 vs. standard blood thinners after knee replacement
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
Sheffield, AlabamaAges 18 years+ - NCT06731673Recruiting
HSP47 protein study in blood clots
This study looks at a protein called HSP47 in people with blood clots, heart attacks, or strokes caused by atrial fibrillation, compared to healthy volunteers. It aims to learn more about how blood clots form and may lead to better treatments.
Aarhus, Central RegionAges 18 years+
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Venous Thromboembolism (VTE) trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for venous thromboembolism (vte)?
- Yes. Clin2 currently lists 53 recruiting venous thromboembolism (vte) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a venous thromboembolism (vte) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a venous thromboembolism (vte) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.